FDA Approves Monkeypox Vaccine, says it May Cause Death in the Vaccinated AND People They Come in Contact With
On August 29 the FDA approved for use in the U.S. a vaccine [ACAM2000] for Monkeypox. While the injection is actually a Smallpox vaccine initially approved in 2007, this new approval allows the shot to be injected into those at ‘high risk’ for the Monkeypox disease, such as those in the LGBTQIAAP2S+ community. It carries with it serious side effect risks, including death to those who have contact with the vaccinated.
“…the FDA approved a new indication for ACAM2000 [the vaccine], to include the prevention of mpox disease in individuals determined to be at high risk for mpox infection. ACAM2000 has been approved since 2007 for the prevention of smallpox disease in individuals determined to be at high risk for smallpox infection. ACAM2000 is a live replicating vaccinia virus vaccine,” an FDA press release said on August 30.
The medication guide found on the FDA’s website for the vaccine lists numerous serious side effects on page 1.